REGISTERED NUMBER: 14217383 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

LAKEWOOD PHARMACY LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

K M Chung

C H A Lam

D Tanna

REGISTERED OFFICE:

114-116 Goodmayes Road

Goodmayes

Essex

IG3 9UZ

REGISTERED NUMBER:

14217383 (England and Wales)

ACCOUNTANTS:

Ashfords Partnership LLP

114 - 116 Goodmayes Road

Ilford

Essex

IG3 9UZ

FIXED ASSETS

Intangible assets

4

190,251

206,648

Tangible assets

5

31,114

36,033

221,365

242,681

CURRENT ASSETS

Stocks

6

90,114

80,139

Debtors

7

127,591

113,546

Cash at bank and in hand

187,840

186,441

405,545

380,126

CREDITORS

Amounts falling due within one year

8

494,802

503,478

NET CURRENT LIABILITIES

(89,257

)

(123,352

)

TOTAL ASSETS LESS CURRENT LIABILITIES

132,108

119,329

PROVISIONS FOR LIABILITIES

11,305

10,293

NET ASSETS

120,803

109,036

CAPITAL AND RESERVES

Called up share capital

1

1

Retained earnings

120,802

109,035

120,803

109,036

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 October 2026 and were signed on its behalf by:

K M Chung - Director

1.	STATUTORY INFORMATION

Lakewood Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2023, is being amortised evenly over its estimated useful life of ten years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Long leasehold

-

in accordance with the property

Plant and machinery

-

25% on reducing balance

Fixtures and fittings

-

25% on reducing balance

Computer equipment

-

33% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Operating leases

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern

The accounts have been prepared on a going concern basis on the assumption that the Company will continue to receive adequate financial assistance from its directors.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2025 - 6 ) .

4.	INTANGIBLE FIXED ASSETS

Computer

Goodwill

software

Totals

£

£

£

COST

At 1 April 2025

250,772

10,667

261,439

Additions

-

10,830

10,830

At 31 March 2026

250,772

21,497

272,269

AMORTISATION

At 1 April 2025

54,754

37

54,791

Amortisation for year

25,077

2,150

27,227

At 31 March 2026

79,831

2,187

82,018

NET BOOK VALUE

At 31 March 2026

170,941

19,310

190,251

At 31 March 2025

196,018

10,630

206,648

5.	TANGIBLE FIXED ASSETS

Fixtures

Long

Plant and

and

Computer

leasehold

machinery

fittings

equipment

Totals

£

£

£

£

£

COST

At 1 April 2025

21,210

2,000

16,562

6,607

46,379

Additions

-

3,390

-

6,221

9,611

At 31 March 2026

21,210

5,390

16,562

12,828

55,990

DEPRECIATION

At 1 April 2025

3,966

918

2,103

3,359

10,346

Charge for year

6,672

1,118

3,615

3,125

14,530

At 31 March 2026

10,638

2,036

5,718

6,484

24,876

NET BOOK VALUE

At 31 March 2026

10,572

3,354

10,844

6,344

31,114

At 31 March 2025

17,244

1,082

14,459

3,248

36,033

6.

STOCKS

31.3.26

31.3.25

£

£

Stocks

90,114

80,139

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Trade debtors

60,468

50,321

Other debtors

67,123

63,225

127,591

113,546

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Trade creditors

139,328

151,693

Amounts owed to group undertakings

322,406

327,071

Taxation and social security

13,662

17,848

Other creditors

19,406

6,866

494,802

503,478

9.	ULTIMATE CONTROLLING PARTY

The company is controlled by the parent company, Ammonite Pharmaceuticals Limited.